Brimofine Benefits & Uses

Brimofine is used to treat the following -

Other Benefits

Glaucoma

Brimofine Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Age Group	Dosage
Adult	Disease: Glaucoma Before or After Meal: As advised by a physician Single Maximum Dose: 1 drop Dosage Route: Ophthalmic Frequency: 3 daily Course Duration: As directed by the doctor Special Instructions: As prescribed by the doctor
Geriatric	Disease: Glaucoma Before or After Meal: As advised by a physician Single Maximum Dose: 1 drop Dosage Route: Ophthalmic Frequency: 3 daily Course Duration: As directed by the doctor Special Instructions: As prescribed by the doctor
13 - 18 years (Adolescent)	Disease: Glaucoma Before or After Meal: As advised by a physician Single Maximum Dose: 1 drop Dosage Route: Ophthalmic Frequency: 3 daily Course Duration: As directed by the doctor Special Instructions: As prescribed by the doctor
2 - 12 years (Child)	Disease: Glaucoma Before or After Meal: As advised by a physician Single Maximum Dose: 1 drop Dosage Route: Ophthalmic Frequency: 3 daily Course Duration: As directed by the doctor Special Instructions: As prescribed by the doctor

Brimofine Side Effects

Based on research, the following side effects have been observed when Brimofine is used -

Moderate

Blurred vision

Mild

Common

Eye Burning
Stinging in the Eyes
Eye itching
Allergic reaction

Brimofine Related Warnings

Is the use of Brimofine safe for pregnant women?

Pregnant women can consume [medicine]. Though Brimofine has mild side effects when taken during pregnany

Mild
Is the use of Brimofine safe during breastfeeding?

In the absence of any scientific study about the side effects of Brimofine in breastfeeding women, information on safety of Brimofine is unavailable.

Unknown
What is the effect of Brimofine on the Kidneys?

Kidney can be affected by Brimofine. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.

Moderate
What is the effect of Brimofine on the Liver?

There may be an adverse effect on the liver after taking Brimofine. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.

Moderate
What is the effect of Brimofine on the Heart?

You may experience side effects on your heart after taking Brimofine. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.

Moderate

Severe Interaction of Brimofine with Other Drugs

Brimofine should not be taken with following medicines due to severe side effects it may cause to patients -

Moderate

Brimofine Contraindications

If you are suffering from any of the following diseases, you should not take Brimofine unless your doctor advises you to do so -

Heart Disease
Depression
Kidney Disease
Liver Disease

Frequently asked Questions about Brimofine

Is this Brimofine habit forming or addictive?

No, there is no any evidence that Brimofine is addictive.

No
Is it safe to drive or operate heavy machinery when consuming?

Brimofine does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.

Safe
Is it safe?

Yes, Brimofine does not show any kind of adverse effect.

Safe
Is it able to treat mental disorders?

Brimofine is unable to treat or cure mental disorders.

No

Brimofine Interactions with Food and Alcohol

Interaction between Food and Brimofine

Taking Brimofine with food is safe.

Safe
Interaction between Alcohol and Brimofine

It is difficult to say anything about the effect of Brimofine and alcohol. No research has been done on this yet.

Unknown

See all substitutes for Brimofine

This medicine data has been created by -

Vikas Chauhan

B.Pharma, Pharmacy
5 Years of Experience

References

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)

Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)

Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)

Brimofine

Brimofine Information